IgM to IgG Class Switching Is a Necessary Step for Pemphigus Phenotype Induction in Desmoglein 3-Specific B Cell Receptor Knock-in Mouse.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
01 02 2022
Historique:
received: 09 08 2021
accepted: 22 11 2021
pubmed: 9 1 2022
medline: 10 2 2022
entrez: 8 1 2022
Statut: ppublish

Résumé

Pemphigus vulgaris is an autoimmune blistering disease caused by IgG targeting desmoglein 3 (Dsg3), an adhesion molecule of keratinocytes. Anti-Dsg3 IgG production is prevented in healthy individuals, but it is unclear how Dsg3-specific B cells are regulated. To clarify the immunological condition regulating Dsg3-specific B cells, a pathogenic anti-Dsg3 Ig (AK23) knock-in mouse was generated. AK23 knock-in B cells developed normally without undergoing deletion or acquiring an anergic phenotype in vivo. The knock-in B cells showed Ca

Identifiants

pubmed: 34996836
pii: jimmunol.2100781
doi: 10.4049/jimmunol.2100781
doi:

Substances chimiques

Desmoglein 3 0
Dsg3 protein, mouse 0
Fcgr2b protein, mouse 0
Immunoglobulin G 0
Immunoglobulin M 0
Receptors, IgG 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

582-593

Informations de copyright

Copyright © 2022 by The American Association of Immunologists, Inc.

Auteurs

Hisashi Nomura (H)

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

Naoko Wada (N)

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.

Hayato Takahashi (H)

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

Yuko Kase (Y)

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

Jun Yamagami (J)

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

Shohei Egami (S)

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
Laboratory for Skin Homeostasis, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.

Hisato Iriki (H)

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

Miho Mukai (M)

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

Aki Kamata (A)

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

Hiromi Ito (H)

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

Hideki Fujii (H)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
Department of Oral Microbiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.

Tomoyuki Ishikura (T)

Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.

Haruhiko Koseki (H)

Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.

Takashi Watanabe (T)

Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.

Taketo Yamada (T)

Department of Pathology, Saitama Medical University, Saitama, Japan; and.

Osamu Ohara (O)

Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.

Shigeo Koyasu (S)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan; shigeo.koyasu@riken.jp amagai@keio.jp amagai@keio.jp.
Laboratory for Immune Cell Systems, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.

Masayuki Amagai (M)

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan; shigeo.koyasu@riken.jp amagai@keio.jp amagai@keio.jp.
Laboratory for Skin Homeostasis, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH